Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Apometrix is a health technology company dedicated to advancing cardiovascular risk assessment through specialized Apolipoprotein B (ApoB) testing. The company provides an at-home diagnostic solution that utilizes a simple finger-prick blood sample to measure the total number of atherogenic particles in the bloodstream. By focusing on ApoB rather than traditional LDL cholesterol, Apometrix offers a more accurate metric for predicting heart disease risk and monitoring the efficacy of lipid-lowering interventions. The platform integrates laboratory results with digital tracking tools to empower patients and clinicians in the field of preventative cardiology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Apometrix.